Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ondansetron Augmentation in Treatment-resistant OCD

This study has been completed.
Information provided by:
Institute of Neuroscience, Florence, Italy Identifier:
First received: February 23, 2011
Last updated: NA
Last verified: February 2011
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)